Female Recruitment Into Cardiovascular Disease Trials

Overview

Journal Am J Cardiol

Specialty Cardiology & Vascular Diseases

Date 2023 May 21

PMID 37210978

Authors

Yingfei Wu

Anagha Prasanna

Hailey N Miller

Oluwabunmi Ogungbe

Anna Peeler

Stephen P Juraschek

Ruth-Alma Turkson-Ocran

Timothy B Plante

Affiliations

Soon will be listed here.

Citing Articles

Sociodemographic predictors of successful screening and subsequent randomization in a digital health hypertension intervention.

Miller H, Askew S, Berger M, Trefney E, Blackman Carr L, Kay M Digit Health. 2024; 10:20552076241281216.

PMID: 39360240 PMC: 11445772. DOI: 10.1177/20552076241281216.

Temporal Trends of Enrollment by Sex and Race in Major Cardiovascular Randomized Clinical Trials.

Sheikh H, Walczak N, Rana H, Tseng N, Syed M, Collier C CJC Open. 2024; 6(2Part B):454-462.

PMID: 38487060 PMC: 10935985. DOI: 10.1016/j.cjco.2023.10.015.

Novel Perspectives in Chronic Kidney Disease-Specific Cardiovascular Disease.

Xu C, Tsihlis G, Chau K, Trinh K, Rogers N, Julovi S Int J Mol Sci. 2024; 25(5).

PMID: 38473905 PMC: 10931927. DOI: 10.3390/ijms25052658.

References

Franconi F, Campesi I, Colombo D, Antonini P . Sex-Gender Variable: Methodological Recommendations for Increasing Scientific Value of Clinical Studies. Cells. 2019; 8(5). PMC: 6562815. DOI: 10.3390/cells8050476. View

Melloni C, Berger J, Wang T, Gunes F, Stebbins A, Pieper K . Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes. 2010; 3(2):135-42. DOI: 10.1161/CIRCOUTCOMES.110.868307. View

Prasanna A, Miller H, Wu Y, Peeler A, Ogungbe O, Plante T . Recruitment of Black Adults into Cardiovascular Disease Trials. J Am Heart Assoc. 2021; 10(17):e021108. PMC: 8649250. DOI: 10.1161/JAHA.121.021108. View

Virani S, Alonso A, Benjamin E, Bittencourt M, Callaway C, Carson A . Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020; 141(9):e139-e596. DOI: 10.1161/CIR.0000000000000757. View

Tsang W, Alter D, Wijeysundera H, Zhang T, Ko D . The impact of cardiovascular disease prevalence on women's enrollment in landmark randomized cardiovascular trials: a systematic review. J Gen Intern Med. 2011; 27(1):93-8. PMC: 3250532. DOI: 10.1007/s11606-011-1768-8. View

Bierer B, White S, Gelinas L, Strauss D . Fair payment and just benefits to enhance diversity in clinical research. J Clin Transl Sci. 2021; 5(1):e159. PMC: 8427546. DOI: 10.1017/cts.2021.816. View

Peterson E, Lytle B, Biswas M, Coombs L . Willingness to participate in cardiac trials. Am J Geriatr Cardiol. 2004; 13(1):11-5. DOI: 10.1111/j.1076-7460.2004.01709.x. View

Lee R, McGinnis K, Sallis J, Castro C, Chen A, Hickmann S . Active vs. passive methods of recruiting ethnic minority women to a health promotion program. Ann Behav Med. 1998; 19(4):378-84. DOI: 10.1007/BF02895157. View

Jin X, Chandramouli C, Allocco B, Gong E, Lam C, Yan L . Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017. Circulation. 2020; 141(7):540-548. DOI: 10.1161/CIRCULATIONAHA.119.043594. View

10.

Johnson D, Joosten Y, Wilkins C, Shibao C . Case Study: Community Engagement and Clinical Trial Success: Outreach to African American Women. Clin Transl Sci. 2015; 8(4):388-90. PMC: 4553110. DOI: 10.1111/cts.12264. View

11.

Cho L, Vest A, ODonoghue M, Ogunniyi M, Sarma A, Denby K . Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives. J Am Coll Cardiol. 2021; 78(7):737-751. DOI: 10.1016/j.jacc.2021.06.022. View